Bausch Health Companies (BHC) Inventory (2009 - 2026)

Bausch Health Companies has disclosed Inventory across 18 years of filings, most recently posting $1.6 billion for Q1 2026.

• Inventory for Q1 2026 came in at $1.6 billion, down 0.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 billion (down 0.74% YoY), and the FY2025 annual result was $1.6 billion, up 2.13% from the prior year.
• Inventory came in at $1.6 billion for Q1 2026 at Bausch Health Companies, down from $1.6 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $1.7 billion in Q3 2024 to a low of $1.0 billion in Q1 2022.
• The 5-year median for Inventory is $1.6 billion (2024), against an average of $1.4 billion.
• Across the five-year window, Inventory surged 41.65% in 2023 and declined 3.44% in 2025, its largest moves.
• Bausch Health Companies' Inventory stood at $1.1 billion in 2022, then soared by 41.65% to $1.5 billion in 2023, then climbed by 3.3% to $1.6 billion in 2024, then advanced by 2.13% to $1.6 billion in 2025, then declined by 1.72% to $1.6 billion in 2026.
• The last three Inventory figures came in at $1.6 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.6 billion (Q3 2025), per Business Quant data.